Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-25 @ 9:36 PM
NCT ID:
NCT01375751
Pre Assignment Details:
Randomization was stratified on the basis of screening LDL-C level (\< 130 mg/dL \[3.4 mmol/L\] or ≥ 130 mg/dL) and ezetimibe use at baseline (yes or no).
Recruitment Details:
Men and women 18 to to 75 years of age, with a diagnosis of heterozygous familial hypercholesterolemia, fasting low-density lipoprotein cholesterol (LDL-C) of ≥ 100 mg/dL, and fasting triglycerides ≤ 400 mg/dL were eligible for this study.
The first patient was enrolled on 02 August 2011 and the last patient was enrolled on 20 February 2012.
Study:
NCT01375751
Study Brief:
Results Section:
NCT01375751